Search Knowledge Base
89 results for "nad"
Niacin
nutrient
Gonadotropin-releasing hormone analogues for endometriosis
pubmed_article
Clinical pharmacokinetics of nadolol: A systematic review
pubmed_article
Evidence Search Results semantic · quality-ranked
Meta-analysis of niacin and NAD metabolite treatment in infectious disease animal studies suggests benefit but requires confirmation in clinically relevant models
meta_analysis
pubmed_article
**Curran et al., 2025** | Sci Rep | Meta Analysis Curran Colleen S, Cui Xizhong, ... Torabi-Parizi Parizad. Meta-analysis of niacin and NAD metabolite treatment in infectious disease animal studies su...
The effects of NAD+ precursor (nicotinic acid and nicotinamide) supplementation on weight loss and related hormones: a systematic review and meta-regression analysis of randomized controlled trials
systematic_review
pubmed_article
**Baichuan et al., 2023** | Front Nutr | Systematic Review Baichuan You, Gomes Reis Marcela, ... Sernizon Guimarães Nathalia. The effects of NAD+ precursor (nicotinic acid and nicotinamide) supplement...
**Morifuji et al., 2024** | Geroscience | Rct Morifuji Masashi, Higashi Seiichiro, ... Nagata Masashi. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, ...
NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence
systematic_review
pubmed_article
**Gallagher et al., 2026** | Ageing Res Rev | Systematic Review Gallagher Cory, Emmanuel Owoturo Oluwaseun. NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of precl...
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
rct
pubmed_article
**Martens et al., 2018** | Nat Commun | Rct Martens Christopher R, Denman Blair A, ... Seals Douglas R. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy mid...
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis
systematic_review
pubmed_article
**Braidy et al., 2020** | Exp Gerontol | Systematic Review Braidy Nady, Liu Yue. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Exp Gerontol. 2020-Apr;132:110831. doi:10....
Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
rct
pubmed_article
**Vreones et al., 2023** | Aging Cell | Rct Vreones Michael, Mustapic Maja, ... Martens Christopher R. Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in pl...
**Simic et al., 2020** | BMC Nephrol | Rct Simic Petra, Vela Parada Xavier Fernando, ... Rhee Eugene P. Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney inj...
**NCT ID**: NCT06579209 **Phase**: NA **Status**: COMPLETED **Enrollment**: 53 **Completion**: 2026-02-20